IRHOM2 palmitoylation decreases ubiquitinated degradation of IRHOM2 and promotes its activation and downstream MAP3K7-JNK signaling, leading to increased hepatic steatosis, inflammation, and collagen accumulation. The gene discussed is RHBDF2; the disease is Hepatic steatosis.